Ferenc Tomosi
Szeged, CS, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cluster headache and kynurenines.
Journal: The journal of headache and pain
Published: January 30, 2023
Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats.
Journal: PloS one
Published: March 06, 2022
Kynurenic acid and kynurenine aminotransferase are potential biomarkers of early neurological improvement after thrombolytic therapy: A pilot study.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: October 12, 2021
Effects of sub-chronic, in vivo administration of sigma non-opioid intracellular receptor 1 ligands on platelet and aortic arachidonate cascade in rats.
Journal: European journal of pharmacology
Published: October 09, 2021
Transition metal-catalysed A-ring C-H activations and C(sp2)-C(sp2) couplings in the 13α-oestrone series and in vitro evaluation of antiproliferative properties.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: March 27, 2021
Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.
Journal: The journal of headache and pain
Published: December 21, 2020
Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity.
Journal: Molecules (Basel, Switzerland)
Published: January 10, 2020
Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Journal: International journal of pharmaceutics
Published: January 10, 2020
A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis.
Journal: Journal of pharmaceutical and biomedical analysis
Published: December 12, 2019
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach.
Journal: Pharmaceutics
Published: December 10, 2019
Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.
Journal: Drug design, development and therapy
Published: July 04, 2019
Last Updated: 09/26/2026